COMBINED THERAPY WITH CAPTOPRIL AND POTASSIUM SUPPLEMENTATION - A POTENTIAL FOR HYPERKALEMIA

被引：41

作者：

BURNAKIS, TG

MIODUCH, HJ

机构：

来源：

ARCHIVES OF INTERNAL MEDICINE | 1984年 / 144卷 / 12期

关键词：

D O I：

10.1001/archinte.144.12.2371

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：2371 / 2372

页数：2

相关论文

共 11 条

[1] CLINICAL USE OF AN ORALLY ACTING CONVERTING ENZYME-INHIBITOR - CAPTOPRIL
BRUNNER, HR
GAVRAS, H
WAEBER, B
TEXTOR, SC
TURINI, GA
WAUTERS, JP
[J]. HYPERTENSION, 1980, 2 (04) : 558 - 566
[2] ACUTE REGIONAL CIRCULATORY AND RENAL HEMODYNAMIC-EFFECTS OF CONVERTING-ENZYME INHIBITION IN PATIENTS WITH CONGESTIVE HEART-FAILURE
CREAGER, MA
HALPERIN, JL
BERNARD, DB
FAXON, DP
MELIDOSSIAN, CD
GAVRAS, H
RYAN, TJ
[J]. CIRCULATION, 1981, 64 (03) : 483 - 489
[3] ANGIOTENSIN INHIBITION IN SEVERE HEART-FAILURE - ACUTE CENTRAL AND LIMB HEMODYNAMIC-EFFECTS OF CAPTOPRIL WITH OBSERVATIONS ON SUSTAINED ORAL-THERAPY
FAXON, DP
CREAGER, MA
SCHICK, EC
HALPERIN, JL
GAVRAS, H
RYAN, TJ
[J]. AMERICAN HEART JOURNAL, 1981, 101 (05) : 548 - 556
[4] CLINICAL-PHARMACOLOGY AND THERAPEUTIC APPLICATIONS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, CAPTOPRIL
FERGUSON, RK
VLASSES, PH
[J]. AMERICAN HEART JOURNAL, 1981, 101 (05) : 650 - 656
[5] GROSSMAN A, 1980, LANCET, V1, P712
[6] GUYTON AC, 1976, TXB MED PHYSL, P482
[7] MASLOWSKI AH, 1981, LANCET, V1, P71
[8] PEARSON RE, 1971, HOSP PHARM, V6, P6
[9] HYPERKALEMIA IN AZOTEMIC PATIENTS DURING ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND ALDOSTERONE REDUCTION WITH CAPTOPRIL
TEXTOR, SC
BRAVO, EL
FOUAD, FM
TARAZI, RC
[J]. AMERICAN JOURNAL OF MEDICINE, 1982, 73 (05) : 719 - 725
[10] VLASSES PH, 1982, PHARMACOTHERAPY, V2, P1